Kiniksa Pharmaceuticals, Ltd. Total Current Liabilities | KNSA

Annual Total Current Liabilities Kiniksa Pharmaceuticals, Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
139 M	101 M	63.7 M	47.1 M	44.8 M	31.8 M	27.8 M	42.6 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
139 M	27.8 M	62.2 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
AnaptysBio ANAB	35.4 M	$ 51.0	1.83 %	$ 1.48 B	USA
Allakos ALLK	17.8 M	-	-	$ 28.6 M	USA
Black Diamond Therapeutics BDTX	15.7 M	$ 1.88	0.53 %	$ 107 M	USA
Clovis Oncology CLVS	125 M	-	-7.23 %	$ 13 M	USA
Concert Pharmaceuticals CNCE	16.1 M	-	-	$ 401 M	USA
Evelo Biosciences EVLO	12.4 M	-	-14.46 %	$ 27.9 M	USA
BioMarin Pharmaceutical BMRN	759 M	$ 60.26	0.06 %	$ 11.6 B	USA
Can-Fite BioPharma Ltd. CANF	2.73 M	$ 2.17	0.46 %	$ 3.57 M	Israel
Freeline Therapeutics Holdings plc FRLN	31 M	-	-	$ 384 M	Britain
Genocea Biosciences GNCA	18.7 M	-	-15.0 %	$ 3.04 M	USA
Catalyst Biosciences CBIO	18.3 M	$ 13.99	0.84 %	$ 1.25 B	USA
C4 Therapeutics CCCC	33 M	$ 2.98	0.3 %	$ 247 M	USA
Codexis CDXS	25.3 M	$ 1.32	1.09 %	$ 115 M	USA
Cerus Corporation CERS	101 M	$ 2.62	0.38 %	$ 499 M	USA
G1 Therapeutics GTHX	29.7 M	-	-	$ 370 M	USA
Coherus BioSciences CHRS	140 M	$ 1.13	0.43 %	$ 132 M	USA
Celldex Therapeutics CLDX	51 M	$ 31.1	1.16 %	$ 2.07 B	USA
CollPlant Biotechnologies Ltd. CLGN	2.67 M	$ 4.25	3.16 %	$ 51.9 M	Israel
Cellectar Biosciences CLRB	4.75 M	$ 1.8	0.72 %	$ 4.69 M	USA
AbbVie ABBV	43.3 B	$ 264.34	0.09 %	$ 468 B	USA
Humanigen HGEN	56.2 M	-	-81.12 %	$ 4.28 M	USA
Cocrystal Pharma COCP	2.21 M	$ 1.17	1.74 %	$ 13.2 M	USA
AbCellera Biologics ABCL	64.3 M	$ 12.7	0.4 %	$ 3.79 B	Canada
Abeona Therapeutics ABEO	29.6 M	$ 5.4	2.65 %	$ 286 M	USA
Collegium Pharmaceutical COLL	440 M	$ 22.53	0.2 %	$ 713 M	USA
Corcept Therapeutics Incorporated CORT	166 M	$ 116.1	4.93 %	$ 12.1 B	USA
Фармсинтез LIFE	1.02 B	-	-	-	Russia
IGM Biosciences IGMS	37.6 M	-	-	$ 76.9 M	USA
Kinnate Biopharma KNTE	12 M	-	-	$ 123 M	USA
Cardiff Oncology CRDF	16.4 M	$ 1.24	0.74 %	$ 82.9 M	USA
Checkmate Pharmaceuticals CMPI	9.38 M	-	-	$ 231 M	USA
Corbus Pharmaceuticals Holdings CRBP	20.7 M	$ 7.14	0.19 %	$ 95.1 M	USA
Karuna Therapeutics KRTX	68.1 M	-	-	$ 12.2 B	USA
Curis CRIS	14.1 M	$ 0.83	1.1 %	$ 10.9 M	USA
CorMedix CRMD	174 M	$ 7.85	1.03 %	$ 565 K	USA
Crinetics Pharmaceuticals CRNX	85.1 M	$ 84.95	0.13 %	$ 7.99 B	USA
CRISPR Therapeutics AG CRSP	149 M	$ 54.23	0.23 %	$ 4.88 B	Schweiz
Champions Oncology CSBR	19.9 M	$ 4.9	0.1 %	$ 67.8 M	USA
Chimerix CMRX	23.9 M	-	-	$ 756 M	USA
Corvus Pharmaceuticals CRVS	9.38 M	$ 11.62	8.21 %	$ 918 M	USA
Cue Biopharma CUE	13.5 M	$ 31.41	1.45 %	$ 2.98 B	USA
CEL-SCI Corporation CVM	5.13 M	$ 1.67	2.38 %	$ 13.4 M	USA
Arbutus Biopharma Corporation ABUS	6.01 M	$ 4.85	0.2 %	$ 929 M	Canada
Cytokinetics, Incorporated CYTK	202 M	$ 64.66	0.17 %	$ 7.77 M	USA
Daré Bioscience DARE	23.7 M	$ 0.78	4.73 %	$ 8.72 M	USA
Adagene ADAG	25.2 M	$ 2.93	2.86 %	$ 173 M	China
DiaMedica Therapeutics DMAC	5.13 M	$ 7.94	1.4 %	$ 373 M	USA